Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Havemann-Reinecke

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of Neural Transmission. Supplementum|January 1, 1995
Injection of apomorphine--a test to predict individual different dopaminergic sensitivity?A Surmann, U Havemann-Reinecke
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1993
Morphine-induced hyperactivity in rats--a rebound effect?B Magnus-Ellenbroek, U Havemann-Reinecke
Psychoneuroendocrinology|November 27, 2018
Gene expression signature in brain regions exposed to long-term psychosocial stress following acute challenge with cannabinoid drugsJ Tomas-Roig, U Havemann-Reinecke
Medizinische Monatsschrift Fur Pharmazeuten|April 4, 1998
[Dopamine and addictive diseases]B Ferger, U Havemann-Reinecke, K Kuschinsky
Scientific Reports|January 19, 2020
Dose-dependent effect of cannabinoid WIN-55,212-2 on myelin repair following a demyelinating insultJ Tomas-Roig, H Y Agbemenyah, N Celarain, et al.
Der Nervenarzt|December 17, 2016
[On the legalization debate of non-medical cannabis consumption : Position paper of the German Association for Psychiatry, Psychotherapy and Psychosomatics]U Havemann-Reinecke, E Hoch, U W Preuss, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 27, 2018
Grey matter structural differences in alcohol-dependent individuals with and without comorbid depression/anxiety-an MRI studyA Uhlmann, B Bandelow, D J Stein, et al.
Der Nervenarzt|October 24, 2015
[Mental comorbidities of alcohol-related disorders]U W Preuss, E Gouzoulis-Mayfrank, U Havemann-Reinecke, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 26, 2017
Psychiatric comorbidity in alcohol use disorders: results from the German S3 guidelinesU W Preuss, E Gouzoulis-Mayfrank, U Havemann-Reinecke, et al.
Pharmacopsychiatry|June 2, 2007
Value and actuality of the prescription information for therapeutic drug monitoring of psychopharmaceuticals: a comparison with the medico-scientific evidenceS Ulrich, C Hiemke, G Laux, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Neural Transmission. Supplementum|January 1, 1995
Injection of apomorphine--a test to predict individual different dopaminergic sensitivity?A Surmann, U Havemann-Reinecke
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1993
Morphine-induced hyperactivity in rats--a rebound effect?B Magnus-Ellenbroek, U Havemann-Reinecke
Psychoneuroendocrinology|November 27, 2018
Gene expression signature in brain regions exposed to long-term psychosocial stress following acute challenge with cannabinoid drugsJ Tomas-Roig, U Havemann-Reinecke
Medizinische Monatsschrift Fur Pharmazeuten|April 4, 1998
[Dopamine and addictive diseases]B Ferger, U Havemann-Reinecke, K Kuschinsky
Scientific Reports|January 19, 2020
Dose-dependent effect of cannabinoid WIN-55,212-2 on myelin repair following a demyelinating insultJ Tomas-Roig, H Y Agbemenyah, N Celarain, et al.
Der Nervenarzt|December 17, 2016
[On the legalization debate of non-medical cannabis consumption : Position paper of the German Association for Psychiatry, Psychotherapy and Psychosomatics]U Havemann-Reinecke, E Hoch, U W Preuss, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 27, 2018
Grey matter structural differences in alcohol-dependent individuals with and without comorbid depression/anxiety-an MRI studyA Uhlmann, B Bandelow, D J Stein, et al.
Der Nervenarzt|October 24, 2015
[Mental comorbidities of alcohol-related disorders]U W Preuss, E Gouzoulis-Mayfrank, U Havemann-Reinecke, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 26, 2017
Psychiatric comorbidity in alcohol use disorders: results from the German S3 guidelinesU W Preuss, E Gouzoulis-Mayfrank, U Havemann-Reinecke, et al.
Pharmacopsychiatry|June 2, 2007
Value and actuality of the prescription information for therapeutic drug monitoring of psychopharmaceuticals: a comparison with the medico-scientific evidenceS Ulrich, C Hiemke, G Laux, et al.
Pageof 3